---
title: "BUZZ-WuXi AppTec's Hong Kong shares climb to over four-year high on robust quarterly results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284294530.md"
datetime: "2026-04-28T02:00:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284294530.md)
  - [en](https://longbridge.com/en/news/284294530.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284294530.md)
---

# BUZZ-WuXi AppTec's Hong Kong shares climb to over four-year high on robust quarterly results

Hong Kong-listed shares of WuXi AppTec (2359.HK) jump 17.5% to HK$148, their highest level since December 2021

Stock marks its biggest intraday pct gain since October 2024, and is top pct gainer in benchmark Hang Seng Index (.HSI) , which slips 0.3%

Shanghai-listed stock (603259.SS) rises 9.9% to 110.5 yuan

China-based new drug developer and manufacturer says its first-quarter net profit up 26.7% y/y to 4.65 billion yuan ($681 million), with revenue up 28.8% y/y to 12.43 billion yuan

YTD, Hong Kong stock up 46.7%, Shanghai-listed shares up 21.9%

($1 = 6.8283 Chinese yuan)

### Related Stocks

- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [00HSI.HK](https://longbridge.com/en/quote/00HSI.HK.md)

## Related News & Research

- [Grand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime](https://longbridge.com/en/news/284576690.md)
- [ZAWYA: Emirates Drug Establishment approves first nasal epinephrine spray as alternative to injections for severe allergic reaction](https://longbridge.com/en/news/284603051.md)
- [05:22 ETEnergenesis Biomedical to Present Clinical Application of ENERGI-F703DFU for Diabetic Foot Ulcers at EWMA 2026](https://longbridge.com/en/news/284533464.md)
- [CMS extends application deadlines for Medicaid drug pricing model](https://longbridge.com/en/news/284622334.md)
- [CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026](https://longbridge.com/en/news/284213122.md)